Search for: "Tom Lamb" Results 521 - 540 of 1,044
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Jun 2011, 2:52 pm by Tom Lamb
Highest Simvastatin Dosage Linked To Potentially Fatal Rhabdomyolysis Muscle Injury And Kidney Failure  (Posted by Tom Lamb at DrugInjuryWatch.com) On June 8, 2011 the FDA announced new dosing restrictions for Zocor and other prescription drug pills containing 80 milligrams (mg) of simvastatin due to their determination these cholesterol drugs are associated, or linked, with an increased risk of developing myopathy and rhabdomyolysis, a serious muscle injury usually… [read post]
17 Jun 2011, 2:37 pm by Tom Lamb
FDA And Health Canada Warn About Increased Risk, While France And Germany Suspend Actos Sales (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE:  "FDA Drug Safety Communication: Updated drug labels for pioglitazone-containing medicines"  (8/4/11) The U.S. [read post]
6 Jun 2011, 1:30 pm by Tom Lamb
Drug Safety Issue Controversy Continues: True Serious Side Effect, Or Attributable To Type 2 Diabetes Condition (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE:  Victoza (liraglutide [rDNA origin]) Injection: REMS - Risk of Thyroid C-cell Tumors, Acute Pancreatitis   [Posted 06/13/2011] AUDIENCE: Endocrinology, Family Practice ISSUE: Novo Nordisk reminded healthcare professionals… [read post]
30 Apr 2009, 12:28 pm
Drug Company Paid Scientific Publisher Elsevier To Produce What Was Essentially A Marketing Publication For Vioxx And Fosamax (Posted by Tom Lamb at DrugInjuryWatch.com) In early April 2009 we heard that there had been some testimony at an Australian Vioxx personal injury trial about a "medical journal" which Merck had created  and distributed to doctors in Australia  apparently to tout the benefits of its (now recalled) blockbuster drug Vioxx. [read post]
15 Jan 2009, 6:59 pm
Today, Patrick Lamb has a great example of this. [read post]